To include your compound in the COVID-19 Resource Center, submit it here.

Codiak raises $76.5M in series C

Exosome therapeutics company Codiak BioSciences Inc. (Cambridge, Mass.) raised $76.5 million in an untranched series C round. Existing investors

Read the full 196 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE